observational
1993
NADH in the treatment of Parkinson's disease: an open-label evaluation of oral and parenteral administration
Birkmayer JGD, Vrecko C, Volc D, Birkmayer W
Published in Acta Neurologica Scandinavica Supplementum
Key Findings
About half of treated Parkinson's patients showed some improvement in disability scores after NADH, with the parenteral route appearing more effective.
Conclusions
Historical uncontrolled data that has never been replicated in a blinded trial.
Limitations
Open label, no control group.
Supplements Studied
NADH
Compound
About half of treated Parkinson's patients improved in an uncontrolled open-label NADH evaluation.
Related Health Concerns
Study Details
Year:1993
Sample Size:885
Quality Score:2/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.